Name | Ca2+ channel agonist 1 |
Synonyms | Ca2+ channel agonist 1 1-Butanol, 2-[[6-[(phenylmethyl)amino]-9-propyl-9H-purin-2-yl]amino]-, (2R)- |
CAS | 1402821-24-2 |
Molecular Formula | C19H26N6O |
Molar Mass | 354.45 |
Solubility | 10 mM in DMSO |
Storage Condition | -20℃ |
In vitro study | Ca 2+ channel agonist 1 (Compound 13d) is an agonist of N-type Ca 2+ channel and an inhibitor of Cdk2, with EC 50 s of 14.23 μM and 3.34 μM, respectively. Ca 2+ channel agonist 1 exhibits a ca. 2-fold increased agonism and a 22-fold decreased cdk2 kinase activity versus the standard, (R)-roscovitine. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.821 ml | 14.106 ml | 28.213 ml |
5 mM | 0.564 ml | 2.821 ml | 5.643 ml |
10 mM | 0.282 ml | 1.411 ml | 2.821 ml |
5 mM | 0.056 ml | 0.282 ml | 0.564 ml |
biological activity | Ca2 channel agnist 1 is an N-type calcium channel (N-type Ca2 channel) agonists and inhibitors of Cdk2, with EC50 of 14.23 μm and 3.34 μm, respectively, have potential effects on motor nerve terminal dysfunction. |